Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AV-001 by Vasomune Therapeutics for Acute Respiratory Distress Syndrome: Likelihood of Approval
AV-001 is under clinical development by Vasomune Therapeutics and currently in Phase II for Acute Respiratory Distress Syndrome. According to...
AV-001 by Vasomune Therapeutics for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
AV-001 is under clinical development by Vasomune Therapeutics and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia. According...
AV-001 by Vasomune Therapeutics for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome: Likelihood of Approval
AV-001 is under clinical development by Vasomune Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated Acute...